Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2003-09-01
2008-12-30
Seaman, D. Margaret (Department: 1625)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C549S355000
Reexamination Certificate
active
07470719
ABSTRACT:
The present invention relates to novel metastable derivatives of benzoxepines of the formula (I) in which n represents 0, 1 or 2; and the radicals R, which may be identical or different, are alkyl or alkoxy groups, or halogen atoms, which can be used in the treatment of dyslipidaemia, atherosclerosis and diabetes.
REFERENCES:
patent: 6596758 (2003-07-01), Brunet et al.
patent: 0212432 (2000-06-01), None
patent: 00/39113 (2000-06-01), None
Bosc Nathali
Boudet Bernard
Festal Didier
Merck Patent GmbH
Millen White Zelano & Branigan P.C.
Rahmani Niloofar
Seaman D. Margaret
LandOfFree
Metastable benzoxepne derivatives which can be used in the... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Metastable benzoxepne derivatives which can be used in the..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Metastable benzoxepne derivatives which can be used in the... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4043060